Bellicum Pharmaceuticals, Inc. Gains 83.64%
Wed, Nov 15, 2023 at 07:48 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) soared at $0.19, representing a gain of 83.6%. On Wed, Nov 15, 2023, BLCM:NASDAQ hit a New 2-Week High of $0.19. From Wed, Nov 01, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 83.64%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 72.51%
- Heron Therapeutics, Inc. (HRTX:NASDAQ), 59.26%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 59.24%
- Ebix, Inc. (EBIX:NASDAQ), 57.66%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 50%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 49.7%
- SciSparc Ltd. (SPRC:NASDAQ), 48.17%
- The Beauty Health Company (SKIN:NASDAQ), 36.69%
- ZK International Group Co., Ltd. (ZKIN:NASDAQ), 36.27%